New in vitro effects of clopidogrel on platelets in hyperlipidemic and healthy subjects.
OBJECTIVE
We aimed to detect novel in vitro effects of clopidogrel on platelets by assessment of the following parameters: malondialdehyde, glutathione, nitrite, aggregation response, and expressions of P-selectin, fibrinogen, apolipoprotein A1, apolipoprotein B, and phosphatidylserine.


METHODS
Platelets were obtained from healthy (n: 9) and hyperlipidemic (n: 9) volunteers. Expressions of P-selectin, fibrinogen, apolipoproteins A1/B and phosphatidylserine with and without clopidogrel were assayed by flow cytometry. Malondialdehyde, glutathione, aggregation and nitrite levels were also assayed.


RESULTS
Without clopidogrel, the baseline values of platelet aggregation, malondialdehyde, and expressions of P-selectin, fibrinogen and phosphatidylserine were significantly higher, whereas nitrite and expression of apolipoproteins A1/B were significantly lower in hyperlipidemics than in the healthy group. In both groups, clopidogrel significantly reduced aggregation and expression of fibrinogen, but it elevated nitrite levels. Clopidogrel significantly decreased P-selectin and phosphatidylserine expression and malondialdehyde but increased expressions of apolipoproteins A1/B only in hyperlipidemics.


CONCLUSIONS
It seems that clopidogrel has some new in vitro antiplatelet effects. The present study is a basic in vitro study to suggest new insights into the effects of clopidogrel on platelet functions.
Tibbiye Cad. No: 49, Haydarpasa, Kadiköy, İstanbul,Turkey Phone: +90 216 450 27 73 E-mail: deryaozsavci@hotmail.com.
Derya
D
Özsavcı
Azize
A
Şener
Rabia
R
Oba
Gülderen
G
Yanıkkaya Demirel
Fikriye
F
Uras
Turay Kevser
TK
Yardımcı